Work

MA12.04 FLAURA2: Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemotherapy in Patients with EGFR-mutated Advanced NSCLC

Year: 2024

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.185

Authors: N. Valdiviezo, J.E. Gray, P.A. Jänne, K. Kobayashi, J.C.-H. Yang, Y. Cheng, C.K. Lee, S. Sugawara, Y. Yu, T.M. Kim, S. Taggart, M. Albayaty, D. Ghiorghui, D. Planchard

Institutions: Instituto Nacional de Enfermedades Neoplásicas, Moffitt Cancer Center, Dana-Farber Cancer Institute, Saitama International Medical Center, Saitama Medical University, National Taiwan University Hospital, Jilin Province Tumor Hospital, St George Hospital, Sendai Kousei Hospital, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Seoul National University Hospital, AstraZeneca (United Kingdom), Université Paris-Saclay, Institut Gustave Roussy

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403410342

Cites:

Cited by: 13

Related to: 10